Please login to the form below

Not currently logged in
Email:
Password:

Parexel launches medical writing solutions business

Will develop a variety of communication services

offering

Biopharmaceutical services provider Parexel has introduced a new offering, one that will see the team deliver an end-to-end offering that provides a wide variety of communication services throughout the drug development and commercialisation process.

The medical writing solutions team is made up of more than 800 employees globally and will develop ‘high-quality’ documents, such as protocols, new drug applications, medical education materials and regulatory authority meeting documents.

Julia Cooper, vice president, head of global medical writing solutions at Parexel, said: “As the drug development journey continues to evolve with the advancements in trial design and technology, and regulatory requirements change, it is vital that clients have access to highly-experienced medical writers who can communicate with all stakeholders in an integrated way, eliminating silos and telling a more holistic story through each stage of development and commercialisation.

“Our deep cross-functional expertise enables us to optimise the medical writing process for our clients, and ultimately allows them to engage more effectively with audiences that are critical in bringing new therapies to market.”

Parexel’s new offering is available as both functional service projects or as part of larger strategic partnerships.

Article by
Gemma Jones

11th April 2018

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cogora

Cogora has been a leader in healthcare publishing for over 30 years and has become one of the leading full-service...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics